2ϩ -activated Cl Ϫ channel expressed on interstitial cells of Cajal (ICC) that has been implicated in slowwave activity in the gut. However, Ano1 is expressed on all classes of ICC, even those that do not contribute to generation of the slow wave, suggesting that Ano1 may have an alternate function in these cells. Ano1 is also highly expressed in gastrointestinal stromal tumors. Mice lacking Ano1 had fewer proliferating ICC in whole mount preparations and in culture, raising the possibility that Ano1 is involved in proliferation. Cl Ϫ channel blockers decreased proliferation in cells expressing Ano1, including primary cultures of ICC and in the pancreatic cancer-derived cell line, CFPAC-1. Cl Ϫ channel blockers had a reduced effect on Ano1 (Ϫ/Ϫ) cultures, confirming that the blockers are acting on Ano1. Ki67 immunoreactivity, 5-ethynyl-2=-deoxyuridine incorporation, and cell-cycle analysis of cells grown in low-Cl Ϫ media showed fewer proliferating cells than in cultures grown in regular medium. We confirmed that mice lacking Ano1 had less phosphorylated retinoblastoma protein compared with controls. These data led us to conclude that Ano1 regulates proliferation at the G1/S transition of the cell cycle and may play a role in tumorigenesis.
TMEM16A; chloride channels; interstitial cells of Cajal; cell cycle; intestine CONTROL OF THE CELL CYCLE is critical to most aspects of biology. Many organs such as the skin and mucosa are constantly turning over; others, such as the liver, proliferate in response to injury (17) . Disruption of the tightly controlled cell cycle can lead to uncontrolled proliferation and tumor formation. Proliferation is a complex cellular process relying on coordinated signaling at key points of the cell cycle. The molecular events of the cell cycle are well characterized, with critical checkpoints at both the G 1 /S and G 2 /M transitions (20) .
Less well known is the role ion channels play in the regulation of cellular proliferation, both for normal proliferation and abnormal proliferation associated with tumor formation. Proliferation requires an increase of cell volume, and this requires ion fluxes across the cell membrane (2) . Controlling cell volume is a critical threshold for cell cycle advancement at the G 2 /M transition. Activity of ion channels has been shown to correlate with progression through both the G 1 /S and G 2 /M transitions (2) although the contribution of ion channels to the regulation of proliferation remains poorly understood. The ion channels more commonly associated with control of proliferation are Cl Ϫ and K ϩ channels; in particular Cl Ϫ channels are associated with regulatory volume decrease (16) . However, ion channels also play a role in late neoplastic stages, stimulating angiogenesis, and regulating cell motility (9) .
A recent addition to the Cl Ϫ channel family is Ano1 (TMEM16A). Ano1 is a Ca 2ϩ -activated Cl Ϫ channel expressed in several epithelia (4, 27, 36) . Mice lacking Ano1 exhibit a defect in epithelial electrolyte transport and a pathology similar to cystic fibrosis (24) . Ano1 is also expressed on interstitial cells of Cajal (ICC) (8) . ICC are the pacemaker cells of the gut and are responsible for propagating the slow wave in the gastrointestinal (GI) tract (13, 32 ). Ano1 appears to be required for normal gastrointestinal physiology as Ano1 (Ϫ/Ϫ) mice have reduced smooth muscle contraction in the stomach (12) , and block of Ano1 or knockout of Ano1 is reported to result in loss of the slow wave (37) . However, Ano1 is expressed on all classes of ICC, even those that are not responsible for the pacemaker function. This raises the possibility that Ano1 has additional functions in these cells.
A potential role for Ano1 in proliferation is suggested by the high expression of the channel in gastrointestinal stromal tumors (GISTs). Ano1 was first discovered in GISTs and given the initial name of DOG1 (discovered on GISTs). Ano1 was described as being ubiquitously expressed on all GISTs (33) although a low percentage of Ano1-negative GISTs has been reported (21) .
The expression of Ano1 on all classes of ICC, including those that do not generate slow waves, the expression of Ano1 in GISTs, and the known role Cl Ϫ plays in regulating cell cycle suggest that Ano1 could be involved in the proliferation of ICC. The aim of this study was to investigate the role of Ano1-mediated Cl Ϫ currents in cellular proliferation using ICC primary cultures from mice and CFPAC-1 cells, a human pancreatic cell line that expresses Ano1.
MATERIALS AND METHODS
Animals. BALB/c mice were obtained from Harlan Sprague-Dawley (Indianapolis, IN). Postnatal day (PND) 0 -4 mice were killed by CO 2 inhalation and cervical dislocation. Ano1
(Ϫ/Ϫ) mice were obtained by breeding mice heterozygous for a targeted disruption of the Ano1 gene (23) . The mice were maintained and the experiments were performed with approval from the Institutional Animal Care and Use Committee of the Mayo Clinic.
Genotyping. Ano1 (Ϫ/Ϫ) mice were rapidly identified by staining the trachea with 0.03% Alcian blue in 25% acetic acid/ethanol, and PCR genotyping was performed to confirm all genotypes. DNA was extracted from tail samples using the Easy-DNA Isolation Kit (Invitrogen, Carlsbad, CA Chemicals. Three structurally different chloride channel blockers were used in our experiments. 4-4=-Diisothiocyanatostilbene-2,2=-disulfonic acid disodium salt (DIDS), tamoxifen, and niflumic acid (all from Sigma) were used at final concentrations between 1 M and 10 M. Stock solutions (50 -100 mM) were made in DMSO (Sigma) and stored at Ϫ20°C. Chemicals were diluted fresh in water on the day of the experiment. DMSO was diluted 1:10 in water and used at a final concentration of 1:10,000 for the vehicle control.
Low-chloride media. Custom M199 media without NaCl, CaCl2, KCl, and phenol red were ordered from Invitrogen. Cl Ϫ was supplemented to a final concentration of 12 mM and 40 mM using NaCl. The remaining ionic salts were replaced with Ca(NO3)2 (Sigma), NaNO3, and KNO3 (both from Fisher Scientific) to maintain osmolality. Commercial M199 medium without phenol red has a concentration of 120 mM Cl Ϫ . Cells were allowed to attach for 24 -48 h in normal growth media before the Cl Ϫ concentration was altered. Immunohistochemistry. Immunohistochemistry was done as previously described (35) . In brief, proliferating cells were identified by either immunoreactivity for the nuclear antigen, Ki67 (Novus and Abcam), or by detection of incorporated 5-ethynyl-2=-deoxyuridine (EdU) using the "Click-iT" technology (Invitrogen). Nuclei were counterstained with 4=,6-diamidino-2-phenylindole dilactate (DAPI). ICC were identified by immunoreactivity for Kit using the antibody ACK2 (eBioscience) and counted using a ϫ20 objective from 35 fields on two separate coverslips per condition.
ICC network volume determination. ICC network volumes were determined from confocal images of whole mount preparations of small intestine tunica muscularis of PND 0 Ano1 (Ϫ/Ϫ) and Ano1
mice. Tissues were labeled for Kit and Ki67 and counterstained with DAPI (for complete methods, see Ref. 31) . Four image stacks of the full thickness of the muscle were collected from each tissue using a ϫ60 (NA 1.2) objective on an FV1000 confocal microscope (Olympus). (ϩ/ϩ) littermates. Protein was prepared by incubating peeled tissue on ice for 5 min in lysis buffer (Cell Signaling) before homogenization and centrifugation. Equal amounts of protein were separated by SDS-PAGE, transferred to PVDF membrane, and incubated with antibodies to retinoblastoma protein (Rb) (1:200 dilution), phosphorylated (Serine 780) Rb (1:1,000 dilution), and GAPDH (1:40,000 dilution) (all from Cell Signaling). All antibodies were diluted in 5% BSA/1ϫ TBS/0.1% Tween. The peak intensity of each band was calculated using the Bio-Rad Quantity One software (BioRad).
Data analysis. Statistical methods used are mentioned within the results.
RESULTS

Ano1
( Fig. 3B ).
There are no specific blockers for Ano1, and, although DIDS, niflumic acid, and tamoxifen block Cl Ϫ channels, they also have other effects (5, 28) . Therefore, to confirm that the effect of Cl Ϫ channel blockers on proliferation was through inhibition of Ano1, we cultured ICC from Ano1 confirming that the blockers were acting on Ano1 and that Ano1 is a mediator of proliferation.
Low-chloride media reduces proliferation in both ICC cultures and CFPAC-1 cells. To further determine the effect of Cl
Ϫ entry on proliferation, we measured proliferation in response to various Cl Ϫ concentrations in the medium. Cl Fig. 5A ). There were also fewer proliferating cells in CFPAC-1 cells when Cl Ϫ was lowered (120 mM, 24.5 Ϯ 5.5; 40 mM, 13.6 Ϯ 4.6; 12 mM, 9.6 Ϯ 3.6; % EdU-positive cells, mean Ϯ SE, n ϭ 3, P Ͻ 0.05, repeatedmeasures ANOVA with Newman-Keuls multiple-comparisons posttest, Fig. 5B) . , 0.435 Ϯ 0.080; means Ϯ SE, n ϭ 7, P Ͼ 0.05, Mann Whitney test, Fig. 7 ].
Proportion of cells in G 1 is increased when cultured in
DISCUSSION
In this study, we show a new function for the recently discovered Ca 2ϩ -activated Cl Ϫ ion channel Ano1 as a regulator of cell proliferation. The contribution of Ano1 to normal Cl Ϫ transport (22) and a link to regulation of gastrointestinal motility has been previously demonstrated (12) . However, a role for Ano1 as a regulator of proliferation has not been reported although it has been proposed, based on the expression of Ano1 expression in tumors (6) . Changes in Cl Ϫ concentration have been associated with specific events of the cell cycle (2), but only a few Cl Ϫ channels have been directly linked to proliferation, specifically the ClC-3 and CLIC5 [chloride intracellular channel 5 (10, 18, 30)] channels. Ano1 joins this group of Cl Ϫ channels. We used multiple approaches to demonstrate a role of Ano1 in the regulation of proliferation. As markers for proliferation we used both Ki67 and EdU incorporation. Ki67 is a nuclear protein that is expressed in all stages of the cell cycle, except for the resting phase, G 0 . Ki67 has a very short half-life (60 -90 min, Ref.
3), making its expression an accurate measure of proliferating cells. EdU is a 5-bromo-2-deoxyuridine (BrdU) analog that can easily be identified by immunohistochemistry or flow cytometry and is only incorporated into the cellular DNA during S-phase. Both methods gave similar results with a decrease in proliferation when Ano1 was genetically or pharmacologically inhibited, suggesting that indeed Ano1 regulates proliferation.
The experiments using whole mounts and primary cultures of ICC from Ano1 (Ϫ/Ϫ) mice showed that Ano1 (Ϫ/Ϫ) mice have fewer proliferating ICC. Furthermore, the experiments quantifying proliferating cells in the circular muscle layers of whole mounts from the mutant mice showed that the difference in proliferation in ICC was not detected in Kit-negative cells in a region; the circular muscle layer that we have shown does not contain Ano1-positive cells (8) . To determine whether the actions of Ano1 were through its function as a Cl Ϫ channel vs. another role for Ano1, we pharmacologically inhibited the channel and also carried out experiments depleting Cl Ϫ in the media. Both sets of experiments yielded similar results, with a decrease in proliferation of ICC and CFPAC-1 cells when Cl Ϫ entry was decreased. These results suggest that regulation of proliferation by Ano1 is related to its function as a Cl Ϫ entry pathway.
The experiments with Cl Ϫ channel blockers are complicated by the lack of specificity of the broad-spectrum blockers used. We chose three structurally different blockers that had previously been shown to block Ano1 currents (11) , but each of these are also well known to have other effects, including inhibition of other Cl Ϫ channels (DIDS, Ref. 28), modulation of estrogen receptor signaling (tamoxifen, Ref. 14) , and effects on K ϩ channels (7) and intracellular Ca 2ϩ for niflumic acid (19) . We therefore carried out the same experiments on ICC from Ano1 (Ϫ/Ϫ) mice and showed that the block in proliferation by the channel blockers was abolished in cells from Ano1 (Ϫ/Ϫ) mice. These data therefore support the argument that the decrease in proliferation induced by the nonspecific Cl Ϫ channel blockers was a specific effect on Ano1. Proliferation was decreased but not abolished in Ano1
mice. This was an expected finding because multiple factors are known to regulate ICC proliferation including Kit (15) and serotonin (31, 34, 35) , and these factors would be expected to maintain their effects on proliferation in the Ano1 (Ϫ/Ϫ) mice and may also compensate for loss of Ano1. Although PND 0 Ano1 (Ϫ/Ϫ) mice had decreased ICC proliferation, ICC network volumes were not significantly different from controls. This likely reflects the fact that ICC networks are not fully formed at birth and continue to develop until PND 11 (25) . The presence of other factors that regulate ICC proliferation as well as the fact that there is extensive pruning of the ICC networks after birth (25) may explain the lack of change in network volumes. It would be interesting to look at the networks at a later time point, specifically after PND 11, but nearly all Ano1 (Ϫ/Ϫ) mice die within the first 24 h of birth (23) , making this experiment very challenging to complete. Furthermore, Cl Ϫ is an important factor for apoptosis (16) , so it is possible that, despite the decrease in proliferation, we still would not be able to detect a difference in ICC network volume because ICC networks in the Ano1 (Ϫ/Ϫ) mice may not undergo normal pruning. In primary cultures the numbers of ICC per field were modestly lower in cultures from knockout mice compared with cultures from control animals but only by 20%, probably attributable to the fact that cell counts and proliferation were by necessity measured at the same time point after plating the cells.
Our findings on the effect of Ano1 on proliferation of ICC and CFPAC-1 cells raise the question of whether Ano1 has a similar role in regulating proliferation in GISTs. GISTs arise from ICC and or ICC precursors (29) . Although GISTs are responsive to inhibitors of Kit and PDGF receptor, these drugs are not curative (1) in part because the presence of Kit-low ICC stem cells in the tumor, which also express Ano1 (1). Ano1 may be important in the progression of GISTs, and, once specific inhibitors for Ano1 are developed, the potential role for these drugs in decreasing GIST proliferation can be tested.
The exact mechanism by which Ano1 regulates cellular proliferation remains to be elucidated. Our work suggests that Cl Ϫ entry is key to its mechanism of action. Furthermore, Ano1
(Ϫ/Ϫ) mice have less phosphorylated Rb, which suggests that the effects of Cl Ϫ entry through Ano1 function at the G 1 /S transition. It is not known but would be interesting to study whether other Cl Ϫ entry pathways have similar effects on normal cell-cycle advancement and cellular proliferation. However, by using CFPAC-1 cells, we excluded a role for the cystic fibrosis transport regulator (CFTR), a Cl Ϫ transporter, in proliferation because of the presence of a loss of function mutation in the CFTR gene in CFPAC-1 cells (26) .
In conclusion, the newly discovered protein Ano1 appears to be a regulator of proliferation in ICC and CFPAC-1 cells. The effect is specifically at the G 1 /S transition in CFPAC-1 cells, suggesting a new role for Ano1 in the control of cellular proliferation and tumorigenesis.
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